title: Pharmacotherapy of pediatric HIV infection.
abstract: The delivery of safe and effective antiretroviral therapy to children and adolescents is crucial to save the lives of millions of children worldwide. The immunologic response to human immunodeficiency infection is closely related to a child's development and creates age-specific parameters for the evaluation of therapeutic response to antiretroviral therapy. Similarly, the development and maturation of organ systems involved in drug absorption, distribution, metabolism, and elimination determines significant changes in the pharmacokinetics of antiretroviral drugs throughout childhood. The authors review the evolution in treatment of pediatric HIV from infancy through adolescence.
authors.affiliation: Division of Infectious Diseases, Children's National Medical Center, Washington, DC 20010, USA. nrakhman@cnmc.org
authors.forename: Natella
authors.initials: N
authors.lastname: Rakhmanina
authors.forename: B Ryan
authors.initials: BR
authors.lastname: Phelps
mesh_terms: D000293:Adolescent; D044966:Anti-Retroviral Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006678:HIV; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D010372:Pediatrics; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*
chemical_list: D044966:Anti-Retroviral Agents